NCT02677870: A trial that was reported late by University Hospitals Cleveland Medical Center
This trial has reported, although it was 128 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02677870 |
|---|---|
| Title | The Effectiveness of High-Dose Synthetic BH4 (Saproterin Dihydrochloride or "Kuvan") in Amish PKU Patients |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 22, 2018 |
| Completion date | Nov. 20, 2018 |
| Required reporting date | Nov. 20, 2019, midnight |
| Actual reporting date | March 27, 2020 |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | 128 |